FDA Approves Alexion's Blood Disorder Drug
Posted on: Monday, 19 March 2007, 15:00 CDT
Alexion Pharmaceuticals has received marketing approval from the FDA for a rare blood disorder drug, Soliris.
Soliris is the first therapy approved for paroxysmal nocturnal hemoglobinuria (PNH), a rare, disabling and life-threatening blood disorder defined by chronic red blood cell destruction, or hemolysis, the company said. Soliris is indicated for the treatment of patients with PNH to reduce hemolysis.
Hemolysis can cause severe anemia, disabling fatigue, recurrent pain, shortness of breath, pulmonary hypertension, intermittent episodes of dark colored urine, kidney disease, impaired quality of life and blood clots.
Patients with PNH are missing a specific protein that normally protects red blood cells from destruction by a component of the immune system called terminal complement. Soliris, the first complement inhibitor approved in the US for the treatment of any disease, prevents hemolysis by selectively blocking terminal complement.
Leonard Bell, CEO of Alexion, said: "Soliris brings real hope to people who live daily with the devastating effects of PNH. With the approval of Soliris, we now have a therapy that dramatically improves the lives of patients suffering from this disease."
Source: Datamonitor
Related Articles
- Heart Disease Patients With Previous Blockages More Likely To Die
- Enhanced Meats Could Spell Trouble for Kidney Disease Patients
- Low blood pressure aids dialysis patients
- Washington Redskins Players, Kidney Disease Patients, Advocates Unveil National Petition Calling on Congress for Additional Kidney Care Support
- Cleviprex(TM) Reduces and Controls Acutely Elevated Blood Pressure in Elderly Patients, According to New Analysis From VELOCITY Trial
- Sixty-One Percent of Newly Diagnosed Parkinson's Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
- Sexual Disease Patients Get Better Social Solicitude in Nepal
- New Study Data in December 9th New England Journal of Medicine Shows Medication May Help Parkinson's Disease Patients With Dementia
- Pretransplant Psychiatric and Medical Comorbidity of Alcoholic Liver Disease Patients Who Received Liver Transplant
- Lowering BP With Medication Provides Unexpected Benefits for Heart Disease Patients With 'Normal' Blood Pressure
 |
 |
User Comments (0)
RSS Feeds